1. Home
  2. BSRR vs NMRA Comparison

BSRR vs NMRA Comparison

Compare BSRR & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$33.17

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

554.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
NMRA
Founded
1977
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
554.0M
IPO Year
2001
2023

Fundamental Metrics

Financial Performance
Metric
BSRR
NMRA
Price
$33.17
$2.33
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$38.50
$6.57
AVG Volume (30 Days)
38.0K
750.9K
Earning Date
04-27-2026
05-11-2026
Dividend Yield
3.10%
N/A
EPS Growth
10.28
57.85
EPS
3.11
N/A
Revenue
N/A
N/A
Revenue This Year
$11.74
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$10.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.42
$0.62
52 Week High
$38.60
$3.65

Technical Indicators

Market Signals
Indicator
BSRR
NMRA
Relative Strength Index (RSI) 41.64 32.03
Support Level $32.93 $1.78
Resistance Level $34.71 $2.58
Average True Range (ATR) 1.09 0.19
MACD 0.07 -0.09
Stochastic Oscillator 57.35 4.44

Price Performance

Historical Comparison
BSRR
NMRA

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: